Skip to Content

Florida Baby First in U.S. Born With COVID-19 Antibodies

THURSDAY, March 18, 2021 -- A Florida baby is believed to be the first in the United States to be born with COVID-19 antibodies after the mother was vaccinated, doctors report.

The mother, a frontline health care worker in South Florida, received her first shot of the Moderna COVID-19 vaccine when she was 36 weeks pregnant and gave birth three weeks later to a healthy baby girl, CBS News reported. Doctors analyzed blood taken from the baby's umbilical cord immediately after birth and before placenta delivery and found that the infant had COVID-19 antibodies.

"We have demonstrated that SARS-CoV-2 IgG antibodies are detectable in a newborn's cord blood sample after only a single dose of the Moderna COVID-19 vaccine," Paul Gilbert, M.D., and Chad Rudnick, M.D., wrote in a preprint study that has not been peer-reviewed. "Thus, there is potential for protection and infection risk reduction from SARS-CoV-2 with maternal vaccination."

The doctors noted that further research is needed to confirm the safety and efficacy of COVID-19 vaccines during pregnancy, CBS News reported.

CBS News Article

© 2021 HealthDay. All rights reserved.

Read this next

Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines

THURSDAY, April 22, 2021 -- In an editorial published online April 15 in the Journal of Allergy and Clinical Immunology: In Practice, an updated pre-COVID-19 vaccine risk...

Decrease Seen in Abusive Head Trauma for Young Children During Pandemic

THURSDAY, April 22, 2021 -- There was a decrease in hospital admissions for children younger than 5 years diagnosed with abusive head trauma (AHT) during the COVID-19 pandemic,...

Recovered but RT-PCR-Positive Individuals Unlikely to Transmit SARS-CoV-2

THURSDAY, April 22, 2021 -- Individuals who have clinically recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and continue to test positive for...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.